» Sign in / Register

CTP - Solution

100 mM Sodium salt solution

Cytidine 5'-triphosphate, Sodium salt

Cat. No. Amount Price (EUR) Buy / Note
NU-1011 1 ml (100 mM)49,90 Add to Basket/Quote Add to Notepad
NU-1011-100ML 100 ml (100 mM) Ask for Quotation
Structural formula of CTP - Solution (100 mM Sodium salt solution, Cytidine 5'-triphosphate, Sodium salt)
Structural formula of CTP - Solution

For general laboratory use.

Shipping: shipped on gel packs

Storage Conditions: store at -20 °C
Short term exposure (up to 1 week cumulative) to ambient temperature possible. If stored as recommended, Jena Bioscience guarantees optimal performance of this product for 12 months after date of delivery.

Shelf Life: 12 months

Molecular Formula: C9H16N3O14P3 (free acid)

Molecular Weight: 483.16 g/mol (free acid)

CAS#: 36051-68-0

EC number: 252-849-3

Purity: ≥ 99 % (HPLC)

Form: clear aqueous solution

Concentration: 100 mM ±2 %

pH: 8.0 ±0.2 (22 °C)

Spectroscopic Properties: λmax 271 nm, ε 8.9 L mmol-1 cm-1 (Tris-HCl pH 7.0)

Physiological role in coronary artery disease[1]
Physiolocal role in lipid metabolism[2]
Physiological role in farnesol induced apoptosis[3]

Ultrapure CTP supplied as clear aqueous solution.

Specific Ligands:

CTP synthase[4]

Phosphocholine cytidyltransferase alpha[2]

Ligand for purinergic receptors:

BIOZ Product Citations:

Selected References:
[1] Lui et al. (2010) Evaluation of CT perfusion in setting of cerebral ischemia:patterns and pitfalls. American Journal of Neuroradiology 31:1552.
[2] Luoma (2010) Gene activation regresses artheriosclerosis, promotes health, and enhances longevity. Lipids in health and disease 9:67.
[3] Joo et al. (2010) Molecular mechanisms involved in farnesol-induced apotosis. Cancer letters 287:123.
[4] Cabeen et al. (2010) A metabolic assembly line in bacteria. Nature Cell Biology 12:731.
[5]Jayasekara et al. (2013) 4-Alkoxyimino-cytosine nucleotides: tethering approaches to molecular probes for the P2Y6 receptor. MedChemComm. 4 (8):1156.
[6]Garzia-Guzman et al. (1997) Molecular characterization and pharmacological properties of the human P2X3 purinoreceptor. Mol. Brain Res. 47 (1):59.
Spangler et al. (2011) Interaction of the diguanylate cyclase YdeH of Escherichia coli with 2', (3')-substituted purine and pyrimidine nucleotides. J. Pharmacol. Exp. Ther. 336 (1):234.